Jue R. Pan
No. 180 Fenglin Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Development of the core-shell nano-system and its application in infective endocarditis: A non-antibiotic therapeutic strategy.
Journal: Biomaterials advances
Published: November 06, 2025
Th2 bias and T-cell exhaustion characterize the immunopathology of non-tuberculous mycobacterial pulmonary disease.
Journal: NPJ systems biology and applications
Published: November 06, 2025
Epidemiology of device-associated healthcare-associated infections and carbapenem-resistant Enterobacteriaceae in intensive care units: a 7-year multicenter surveillance in Shanghai, China.
Journal: Infection control and hospital epidemiology
Published: September 15, 2025
Case Report: A Pulmonary Cryptococcosis Presenting as Interstitial Pneumonia in a Patient of IgA Nephropathy.
Journal: Infection and drug resistance
Published: September 08, 2025
Characterization of Prophages and Their Genetic Cargo in Clinical M. abscessus Isolates.
Journal: Microorganisms
Published: July 21, 2025
Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance when applied in paucibacillary clinical samples.
Journal: Microbiology spectrum
Published: June 10, 2025
High-throughput clinical antimicrobial susceptibility testing and drug-resistant subpopulation detection in Gram-negative bacteria.
Journal: Microbiology spectrum
Published: June 05, 2025
Phage-host interaction in Pseudomonas aeruginosa clinical isolates with functional and altered quorum sensing systems.
Journal: Applied and environmental microbiology
Published: March 04, 2025
Imaging and serum antigen levels that influence the treatment and prognosis of cryptococcosis in immunocompetent and immuno-compromised patients: A 10-year retrospective study.
Journal: Drug discoveries & therapeutics
Published: February 26, 2025
Corticosteroid dose escalation in non-ICU COVID-19 patients with worsening lung lesions reduces lesion severity without improving clinical outcomes.
Journal: Drug discoveries & therapeutics
Published: December 25, 2024
Last Updated: 09/26/2026